Impact of an Oligomeric Diet in Intestinal Absorption and Inflammatory Markers in Patients With Crohn Disease
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Absorption; Disorder
- Absorption; Disorder, Carbohydrate
- Absorption; Disorder, Fat
- Absorption; Disorder, Protein
- Crohn Disease
- Malnutrition
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Multicentric, parallel, randomized, double blind and controlled clinical-nutritional study of 6 months of intervention and 3 study groups of treatment: Experimental group (peptidic diet with a mix of probiotics); Experimental group with placebo (peptidic diet with a placebo); and Control group (cont...
Multicentric, parallel, randomized, double blind and controlled clinical-nutritional study of 6 months of intervention and 3 study groups of treatment: Experimental group (peptidic diet with a mix of probiotics); Experimental group with placebo (peptidic diet with a placebo); and Control group (control with a polymeric nutritional oral supplement with a placebo) to evaluate the effect on the nutritional status, inflammatory markers and the intestinal absorption
Tracking Information
- NCT #
- NCT04305535
- Collaborators
- Adventia Pharma, S.L.
- Biopolis S.L.
- Investigators
- Principal Investigator: Miguel Aganzo-Yeves, RD Hospital Universitario Fundación Jiménez Díaz Study Director: Clotilde Vázquez-Martínez, MD Hospital Universitario Fundación Jiménez Díaz
Get Well Soon